Evidence map›Paper›PMID 31897316›Full record

ArticleSultan Qaboos University medical journal2019

Determination of Pathogenicity of

Angela Brown, Mansour Zamanpoor, Donald R Love, Debra O Prosser

Open access · diamondAbstract read
In one paragraph

Article in Sultan Qaboos University medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Reclassification ofBiomolecules & biomedicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Angela BrownWellington Regional Genetics Laboratory, Wellington Hospital, Wellington, New Zealand.
Mansour ZamanpoorWellington Regional Genetics Laboratory, Wellington Hospital, Wellington, New Zealand.
Donald R LoveDiagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
Debra O ProsserDiagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
Auckland City Hospital · NZWellington Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMolecular diagnostic laboratories screen for mutations in disease-causing genes in order to confirm a clinical diagnosis. The classification of DNA variants as 'pathogenic' or 'likely pathogenic' mutations creates a workflow bottleneck, which becomes increasingly challenging as greater number of genes are screened. The classification challenge is also acute if there are conflicting reports regarding pathogenicity and differing classification criteria between laboratories. This study aimed to compare two procedures for the classification of variants in the

methodsThis bioinformatic study was conducted at LabPLUS, Auckland, New Zealand, from February to June 2017. DNA was extracted from peripheral blood samples of 30 patients and gene library construction was carried out using a commercially available targeted panel for the

resultsThe results showed concordance between the two classification protocols for a panel of 30

conclusionThe ACMG/AMP-based guidelines were applied to a cohort of patients with

Indexed as

Genes, BRCA1Genes, BRCA2Genetic VariationPractice Guidelines as TopicBenchmarkingBreast NeoplasmsFemaleGenetic TestingHumansNew ZealandReproducibility of ResultsSequence Analysis, DNASocieties, MedicalBioinformaticsBRCA1 GeneDNA SequencingNew ZealandNonsense CodonSplice Donor Site

Identifiers

PMID31897316
PMCPMC6930041
OpenAlexW2998198227

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.